IONIS-FB-LRx
Geographic Atrophy (GA)
Phase 3Active
Key Facts
About Ionis Pharmaceuticals
Ionis Pharmaceuticals is a commercial-stage biotech leader with a mission to discover and deliver life-changing RNA-targeted medicines. The company has achieved multiple industry firsts, including the first approved antisense drug, and has successfully transitioned from a research-focused entity to a fully integrated organization with its own commercial capabilities. Its strategy centers on independently launching medicines in neurology and cardiology while selectively partnering in other areas, backed by a deep, late-stage pipeline and a sustainable technology platform.
View full company profileTherapeutic Areas
Other Geographic Atrophy (GA) Drugs
| Drug | Company | Phase |
|---|---|---|
| NGM621 | NGM Biopharmaceuticals | Phase 2 |
| K8 Implant | Inflammasome Therapeutics | Phase I/II |
| ANX007 | Annexon Biosciences | Phase 2/3 |